Stock Market Reviews, 12 Aug 2010
(RTTNews) - Temasek Life Science Ventures Pte Ltd. and Emergent BioSolutions Inc. (EBS) Wednesday jointly said that they have agreed to form EPIC BIO Pte Ltd, a joint venture to develop, manufacture, and commercialize a multivalent, cross-protective human vaccine to protect against influenza caused by a broad range of circulating H5 influenza strains. EPIC BIO will be based in Singapore.
Full Story